Literature DB >> 1080741

Immunosuppressor T cells in tumor bearing host.

S Fujimoto, M Greene, A H Sehon.   

Abstract

Thymus or spleen cells of tumor bearing animals (TBA) (methylcholanthrene induced sarcoma bearing A/Jax mice) were shown to possess immunosuppressor cells regulating the immune response to the tumor in syngeneic animals. The immunosuppressive activity of these cells of TBA was totally abolished by the in vitro treatment of anti-theta serum and complement. Soluble factor(s) with identical suppressive activity was isolated from the thymus cells of TBA and its molecular size was estimated to be lower than that of serum albumin in terms of its elution behaviour on gel filtration through a Sephadex G-200 column. These immunosuppressor T cells or their soluble factor(s) may be largely responsible for the growth of antigenic tumors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080741     DOI: 10.3109/08820137409055774

Source DB:  PubMed          Journal:  Immunol Commun        ISSN: 0090-0877


  14 in total

1.  Suppressor cell activity in peripheral blood in cancer patients after surgery.

Authors:  I Grzelak; W L Olszewski; A Engeset
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

Review 2.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

Review 3.  Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.

Authors:  Yan Xiao; Bin Li; Zhaocai Zhou; Wayne W Hancock; Hongtao Zhang; Mark I Greene
Journal:  Curr Opin Immunol       Date:  2010-09-24       Impact factor: 7.486

Review 4.  FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.

Authors:  Changhua Zhuo; Ye Xu; Mingang Ying; Qingguo Li; Liyong Huang; Dawei Li; Sanjun Cai; Bin Li
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 5.  Lymphocytes in cancer development: polarization towards pro-tumor immunity.

Authors:  Brian Ruffell; David G DeNardo; Nesrine I Affara; Lisa M Coussens
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-11       Impact factor: 7.638

Review 6.  Emerging strategies for cancer immunoprevention.

Authors:  J C Roeser; S D Leach; F McAllister
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

7.  In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer.

Authors:  R E Garner; A P Malick; K M Connolly; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.

Authors:  Yewen Shi; Tong-Xin Xie; David G Leach; Bingbing Wang; Simon Young; Abdullah A Osman; Andrew G Sikora; Xiaoyong Ren; Jeffrey D Hartgerink; Jeffrey N Myers; Roberto Rangel
Journal:  Cancer Prev Res (Phila)       Date:  2021-05-21

Review 9.  How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development.

Authors:  Guillaume Darrasse-Jèze; Katrina Podsypanina
Journal:  Front Immunol       Date:  2013-09-26       Impact factor: 7.561

10.  In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.

Authors:  L A Dent; J J Finlay-Jones
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.